SPIRE-LL (Completed)
STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AT RISK OF CARDIOVASCULAR EVENTS
- Medicine
- PF-04950615 (PCSK9)
- Population
- Primairy prevention cardiovasular disease
- Phase
- III
- Starting year
- 2014
- More information
- clinicaltrials.gov